CytoSorbents(CTSO) - 2024 Q4 - Annual Results

Financial Results Announcement - CytoSorbents Corporation announced preliminary and unaudited financial results for the quarter and year ended December 31, 2024[4] - The press release detailing the financial results and business updates was issued on January 3, 2025[4] Regulatory and Filing Information - The financial results are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934[4] - The press release is furnished as Exhibit 99.1 in the Form 8-K filing[4] Executive Signatory - The report was signed by Dr. Phillip P. Chan, Chief Executive Officer of CytoSorbents Corporation[7]